Clinical Trial Update: Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection [NA]

View source ↗

Summary

A completed clinical trial evaluating the safety and efficacy of a fixed-dose combination of dolutegravir/abacavir/lamivudine initiated during acute HIV infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• dolutegravir/abacavir/lamivudine fixed-dose combination (dolutegravir/abacavir/lamivudine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV, Acute HIV Infection | NA | Status: COMPLETED | Results posted: 2021-11-22